These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15610132)

  • 1. Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial.
    PR06 Collaborators
    BJU Int; 2004 Dec; 94(9):1400-1. PubMed ID: 15610132
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Scandinavian Prostate Cancer Group Study: the case for conservative management.
    Parker C
    BJU Int; 2005 Nov; 96(7):952-3. PubMed ID: 16225505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early definite treatment for elderly patients with localized prostate cancer].
    Komatsu K
    Hinyokika Kiyo; 2005 Aug; 51(8):565-6. PubMed ID: 16164274
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 6. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
    Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
    BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. We need better randomized comparison trials of prostate cancer.
    Lee WR
    Cancer; 2010 Jan; 116(2):270-2. PubMed ID: 19924796
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving informed consent in clinical trials: successful piloting of a decision aid.
    Juraskova I; Butow P; Lopez AL; Seccombe M; Boyle F; McCarthy N; Forbes JF
    J Clin Oncol; 2007 Apr; 25(11):1443-4; author reply 1444. PubMed ID: 17416867
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells.
    Lin AM; Hershberg RM; Small EJ
    Urol Oncol; 2006; 24(5):434-41. PubMed ID: 16962496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
    Frattaroli J; Weidner G; Dnistrian AM; Kemp C; Daubenmier JJ; Marlin RO; Crutchfield L; Yglecias L; Carroll PR; Ornish D
    Urology; 2008 Dec; 72(6):1319-23. PubMed ID: 18602144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-risk prostate cancer patient: active treatment.
    Moul JW; Saad F
    Can J Urol; 2005 Jun; 12 Suppl 2():25-7. PubMed ID: 16018829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for prostate cancer with serum prostate-specific antigen : what should we recommend while waiting for randomized clinical trial results?
    Davis JW
    Cancer; 2008 Dec; 113(11):3067-8. PubMed ID: 18932255
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial.
    Schulz RJ; Kagan AR
    J Natl Cancer Inst; 2009 Jan; 101(2):124. PubMed ID: 19141784
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?
    Ganswindt U; Stenzl A; Bamberg M; Belka C
    Eur Urol; 2008 Sep; 54(3):528-42. PubMed ID: 18602742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of active surveillance in prostate cancer: the PRIAS study.
    van den Bergh RC; Roemeling S; Roobol MJ; Roobol W; Schröder FH; Bangma CH
    Eur Urol; 2007 Dec; 52(6):1560-3. PubMed ID: 17532115
    [No Abstract]   [Full Text] [Related]  

  • 18. PSA-based screening for localised prostate cancer. Uncertain benefits, potential adverse consequences, and many outstanding questions.
    Prescrire Int; 2009 Oct; 18(103):225. PubMed ID: 19882799
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine therapy for prostate cancer.
    Sonpavde G; Spencer DM; Slawin KM
    Urol Oncol; 2007; 25(6):451-9. PubMed ID: 18047951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.